| related words |
| diagnostic |
| genetic |
| efficacy |
| commercialized |
| unproven |
| vaccine |
| therapeutic |
| hematide |
| rigorous |
| safer |
| tm |
| cubicin |
| bidil |
| tarceva |
| preclinical |
| milestone |
| protocol |
| melafind |
| blood |
| cryoablation |
|
| related documents |
| 1088856--3/26/2010--CORCEPT_THERAPEUTICS_INC |
| 1010086--3/6/2009--SIGA_TECHNOLOGIES_INC |
| 1367644--3/6/2009--Emergent_BioSolutions_Inc. |
| 1005201--3/6/2009--DEPOMED_INC |
| 1088856--3/31/2009--CORCEPT_THERAPEUTICS_INC |
| 1367644--3/10/2008--Emergent_BioSolutions_Inc. |
| 1088856--3/31/2008--CORCEPT_THERAPEUTICS_INC |
| 1367644--3/27/2007--Emergent_BioSolutions_Inc. |
| 1088856--3/30/2006--CORCEPT_THERAPEUTICS_INC |
| 1088856--4/2/2007--CORCEPT_THERAPEUTICS_INC |
| 919722--3/16/2007--SUPERGEN_INC |
| 919722--3/16/2006--SUPERGEN_INC |
| 1261654--12/1/2010--UNIVERSAL_TECHNICAL_INSTITUTE_INC |
| 803014--10/4/2010--COMVERSE_TECHNOLOGY_INC/NY/ |
| 929887--10/21/2010--APOLLO_GROUP_INC |
| 880059--9/1/2010--EDUCATION_MANAGEMENT_CORPORATION |
| 831547--4/5/2010--SPECTRUM_PHARMACEUTICALS_INC |
| 1450390--4/7/2010--MULTISYS_LANGUAGE_SOLUTIONS_INC |
| 73048--6/29/2010--BROADVIEW_INSTITUTE_INC |
| 881524--3/10/2010--VIVUS_INC |
|
| related topics |
| {product, candidate, development} |
| {regulation, government, change} |
| {product, liability, claim} |
| {control, financial, internal} |
| {cost, operation, labor} |
| {financial, litigation, operation} |
| {tax, income, asset} |
| {product, market, service} |
| {loan, real, estate} |
| {gas, price, oil} |
| {interest, director, officer} |
| {customer, product, revenue} |
| {provision, law, control} |
| {regulation, change, law} |
| {operation, international, foreign} |
| {cost, regulation, environmental} |
| {stock, price, share} |
| {system, service, information} |
| {property, intellectual, protect} |
| {operation, natural, condition} |
|